Pinion Immunotherapeutics focuses on developing innovative immunotherapies aimed at treating cancer and autoimmune diseases. The company leverages its proprietary platform to create a range of therapeutic candidates that harness the body's immune system to target and eliminate diseased cells. Their pipeline includes various product candidates that are designed to enhance immune responses, improve patient outcomes, and provide more effective treatment options compared to traditional therapies.

The technologies employed by Pinion Immunotherapeutics are centered around the modulation of immune pathways and the development of targeted therapies. This includes the use of engineered immune cells and biologics that can specifically recognize and attack cancer cells or modulate immune responses in autoimmune conditions. By integrating advanced scientific research with clinical insights, Pinion aims to deliver next-generation immunotherapies that are both safe and effective, ultimately transforming the landscape of treatment for patients with challenging diseases.

United States

Pinion Immunotherapeutics is a Maryland based biotechnology company passionate about innovating safer and more efficient RNA preventive vaccines for infectious diseases and therapeutic vaccines for cancer.

Pinion Immunotherapeutics

Company Details